Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Turkey In-vitro Fertilization Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technique (ICSI IVF v/s Non-ICSI/Traditional IVF)
5.2.2. By Reagent (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media)
5.2.3. By Instruments (Imaging Systems, Sperm Separation Systems, Ovum Aspiration Pumps, Incubators, Micromanipulator Systems, Cryo-systems, Others)
5.2.4. By Infertility (Female v/s Male)
5.2.5. By Embryo (Frozen-Thawed Embryo v/s Fresh Embryo)
5.2.6. By Application (Fertility Clinics, Hospitals, Others)
5.2.7. By End User (Locals, Expats, Medical Tourists)
5.2.8. By Region
5.2.9. By Company (2022)
5.3. Market Map
5.3.1. By Technique
5.3.2. By Reagent
5.3.3. By Instruments
5.3.4. By Infertility
5.3.5. By Embryo
5.3.6. By Application
5.3.7. By End User
5.3.8. By Region
6. ICSI In-vitro Fertilization Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Reagent (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media)
6.2.2. By Instruments (Imaging Systems, Sperm Separation Systems, Ovum Aspiration Pumps, Incubators, Micromanipulator Systems, Cryo-systems, Others)
6.2.3. By Infertility (Female v/s Male)
6.2.4. By Embryo (Frozen-Thawed Embryo v/s Fresh Embryo)
6.2.5. By Application (Fertility Clinics, Hospitals, Others)
6.2.6. By End User (Locals, Expats, Medical Tourists)
7. Non-ICSI/Traditional In-vitro Fertilization Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Reagent (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media)
7.2.2. By Instruments (Imaging Systems, Sperm Separation Systems, Ovum Aspiration Pumps, Incubators, Micromanipulator Systems, Cryo-systems, Others)
7.2.3. By Infertility (Female v/s Male)
7.2.4. By Embryo (Frozen-Thawed Embryo v/s Fresh Embryo)
7.2.5. By Application (Fertility Clinics, Hospitals, Others)
7.2.6. By End User (Locals, Expats, Medical Tourists)
8. Market Dynamics
8.1. Drivers
8.2. Challenges
9. Market Trends & Developments
10. Policy & Regulatory Landscape
11. Turkey Economic Profile
12. Turkey In-vitro Fertilization: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Pricing Analysis
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis
15.6.1. Medical Park Group
15.6.2. Medipol University Hospital
15.6.3. Hisar Hospital Intercontinental
15.6.4. Liv Hospital
15.6.5. Antolia IVF and Women’s Health Centre
15.6.6. Acibadem Hospitals Group
15.6.7. Florence Nightingale Hospital
15.6.8. American Hospital
15.6.9. Memorial Hospitals Group
15.6.10. Medicana International
15.6.11. Koc University Hospital
16. Strategic Recommendations